Evidence map›Paper›PMID 36230133›Full record

ReviewFoods (Basel, Switzerland)2022

Research Advances in the Analysis of Estrogenic Endocrine Disrupting Compounds in Milk and Dairy Products.

Jia Chang, Jianhua Zhou, Mingyang Gao, Hongyan Zhang, Tian Wang

Open access · goldAbstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Breast Cancer Exposomics.Life (Basel, Switzerland) · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jia ChangShandong Provincial Key Laboratory of Animal Resistance Biology, Key Laboratory of Food Nutrition and Safety, College of Life Sciences, Shandong Normal University, Jinan 250014, China.
Jianhua ZhouShandong Provincial Key Laboratory of Animal Resistance Biology, Key Laboratory of Food Nutrition and Safety, College of Life Sciences, Shandong Normal University, Jinan 250014, China.
Mingyang GaoShandong Provincial Key Laboratory of Animal Resistance Biology, Key Laboratory of Food Nutrition and Safety, College of Life Sciences, Shandong Normal University, Jinan 250014, China.
Hongyan ZhangShandong Provincial Key Laboratory of Animal Resistance Biology, Key Laboratory of Food Nutrition and Safety, College of Life Sciences, Shandong Normal University, Jinan 250014, China.ORCID 0000-0001-6424-3261
Tian WangShandong Provincial Key Laboratory of Animal Resistance Biology, Key Laboratory of Food Nutrition and Safety, College of Life Sciences, Shandong Normal University, Jinan 250014, China.
Shandong Normal University · CN

Funding

Key Program of the Natural Science Foundation of Shandong Province ZR2020KC031National Natural Science Foundation of China 31871874
6 · The paper itself

Abstract

Milk and dairy products are sources of exposure to estrogenic endocrine disrupting compounds (e-EDCs). Estrogenic disruptors can accumulate in organisms through the food chain and may negatively affect ecosystems and organisms even at low concentrations. Therefore, the analysis of e-EDCs in dairy products is of practical significance. Continuous efforts have been made to establish effective methods to detect e-EDCs, using convenient sample pretreatments and simple steps. This review aims to summarize the recently reported pretreatment methods for estrogenic disruptors, such as solid-phase extraction (SPE) and liquid phase microextraction (LPME), determination methods including gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), Raman spectroscopy, and biosensors, to provide a reliable theoretical basis and operational method for e-EDC analysis in the future.

Indexed as

analysisdairy productsestrogenic disrupting compoundspretreatment

Identifiers

PMID36230133
PMCPMC9563511
OpenAlexW4303644870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.